MEDICO REMEDIES LIMITED (MEDICO)

NSE: ₹45.91
BSE: ₹45.83
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 31.47 42.36 29.77 41.32 30.80 39.35 39.49 41.30 38.25 52.64 58.68 56.81
YOY Revenue Growth % -5.03% 4.68% -23.36% 47.63% -2.13% -7.1% 32.64% -0.05% 24.2% 33.76% 48.6% 37.54%
Other Income 0.31 0.96 0.27 0.58 0.29 0.68 1.43 0.29 0.66 1.72 0.68 2.87
Total Income 31.78 43.31 30.05 41.91 31.09 40.03 40.91 41.60 38.91 54.36 59.36 59.68
Total Expenses + 29.90 40.17 27.98 37.66 28.92 37.90 37.42 35.90 36.48 50.89 55.53 51.36
Cost of Materials Consumed 22.44 29.75 24.26 29.65 22.55 28.49 30.93 29.42 28.71 43.35 36.18 40.34
Employee Benefit Expense 1.36 1.48 1.72 1.36 1.44 1.38 1.88 1.58 1.70 1.81 2.13 1.76
Other Expenses 3.78 3.72 3.76 4.92 4.49 5.31 5.84 5.69 6.38 7.66 8.11 8.46
Operating Profit 1.57 2.19 1.79 3.66 1.88 1.45 2.07 5.41 1.78 1.75 3.16 5.45
OPM % 5% 5.2% 6% 8.9% 6.1% 3.7% 5.2% 13.1% 4.6% 3.3% 5.4% 9.6%
Profit Before Tax + 1.88 3.14 2.06 4.25 2.18 2.13 3.50 5.70 2.43 3.47 3.83 8.32
Tax Expense 0.56 0.72 0.62 1.15 0.60 0.58 0.88 1.36 0.62 0.91 0.96 2.46
Tax % 29.9% 22.8% 29.9% 27% 27.4% 27.1% 25.1% 23.8% 25.3% 26.1% 25% 29.6%
Profit After Tax 1.32 2.43 1.45 3.10 1.58 1.55 2.62 4.34 1.82 2.57 2.87 5.86
EPS (Basic) 0.16 0.29 0.17 0.37 0.19 0.19 0.32 0.52 0.22 0.31 0.35 0.71

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 206.38 150.94 144.92 140.44 121.02 122.39 88.64
YOY Revenue Growth % 36.73% 4.15% 3.19% 16.04% -1.12% 38.08% -
Other Income 5.93 2.69 2.13 3.95 2.03 1.03 2.10
Total Income 212.31 153.63 147.05 144.38 123.05 123.42 90.73
Total Expenses + 194.25 140.13 135.71 134.29 116.50 119.73 88.52
Cost of Materials Consumed 148.59 111.39 106.10 100.07 84.67 87.58 68.93
Employee Benefit Expense 7.40 6.28 5.92 5.68 5.45 4.50 3.83
Other Expenses 30.62 21.33 16.18 20.27 21.07 20.47 14.79
Operating Profit 12.13 10.81 9.21 6.15 4.52 2.65 0.12
OPM % 5.9% 7.2% 6.4% 4.4% 3.7% 2.2% 0.1%
Profit Before Exceptional 18.06 13.50 11.34 10.10 0.00 0.00 0.00
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 18.06 13.50 11.34 10.10 6.55 3.69 2.22
Tax Expense 4.94 3.41 3.04 2.86 6.55 3.69 2.22
Tax % 27.4% 25.3% 26.9% 28.3% 100% 100% 100%
Profit After Tax 13.12 10.09 8.29 7.24 0.00 0.00 0.00
EPS (Basic) 1.58 1.22 1.00 0.87 2.95 6.25 3.93

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 24.49 22.95 22.43 22.91 17.64 17.08 18.63
Property, Plant & Equipment 20.10 20.53 20.27 20.31 0.00 0.00 0.00
Capital Work in Progress 2.57 1.05 1.11 1.52 0.00 0.00 0.00
Non-Current Investments 0.04 0.20 0.20 0.00 0.00 0.11 0.15
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.04 0.07 0.12 0.00 0.00 0.00 0.00
Current Assets + 128.92 96.68 73.76 64.54 58.56 58.54 56.64
Inventories 30.02 26.73 16.34 19.70 18.11 14.55 18.26
Trade Receivables 81.99 57.18 49.63 36.09 0.00 0.00 0.00
Cash and Cash Equivalents 1.91 1.09 0.18 0.91 1.17 2.83 1.41
Current Investments 1.84 1.45 1.36 0.00 0.00 1.06 0.00
LIABILITIES & EQUITY
Total Equity 75.47 62.29 52.37 43.84 0.00 0.00 0.00
Equity Share Capital 16.60 16.60 16.60 16.60 0.00 0.00 0.00
Other Equity 58.88 45.70 35.77 27.25 0.00 0.00 0.00
Non-Current Liabilities 0.29 0.37 1.01 2.08 0.98 5.21 4.92
Current Liabilities 77.64 56.96 42.81 41.52 37.90 37.95 40.48
Total Liabilities 77.93 57.33 43.82 43.61 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 5.87 4.89 2.44 8.17 6.03 2.61 0.00
Cash from Investing Activities -4.51 -3.46 -2.68 -6.60 -2.11 -0.08 0.00
Cash from Financing Activities -0.55 -0.52 -0.49 -1.82 -5.59 -0.35 0.00
Net Increase/Decrease in Cash 0.81 0.91 -0.73 -0.25 -1.67 2.18 0.00